COVID-19 Cases In Selected Hospitals of CEBUDOC Group from March 2020 to March 2021


  • Emmalyn Cutamora Cebu Doctors' University
  • Cris Bon C. Sabugal Cebu Doctors' University
  • Devie Elis M. Anonas Cebu Doctors' University
  • Jean Shelou M. Maga Cebu Doctors' University
  • Prince Myrielle B. Leornas Cebu Doctors' University
  • Queeny Beb B. Rendon Cebu Doctors' University


Comorbidity, COVID-19 cases, CebuDoc Group, demographic profile


This study determines the number of COVID-19 cases in the three selected tertiary hospitals of the CebuDoc Group. Results showed that most of the patients confined in the three tertiary hospitals were aged 60-69 (21.7%), the majority of them were males (55.3%) and patients admitted in these three  hospitals did not have comorbidities (67.9%). For those who had comorbidities, the most common were cardiovascular disease (42.24%), followed by systemic disease (30.53%) and renal disease (15.39%). In Cebu Doctors University Hospital (CDUH), March 2021 had the most number recorded with 155 cases. In Mactan Doctors Hospital (MDH), July 2020 had the most number recorded with 55 cases, while in North General Hospital (NGH), February 2021 had the most number with 69 COVID-19 cases. Overall, there were 760 COVID-19 cases in the three selected hospitals in the CebuDoc Group from March 2020 to March 2021.


Alkhouli, M., Nanjundappa, A., Annie, F., Bates, M., Bhatt, D. (2020). Sex differences in case fatality rate of COVID-19: insights from a multinational registry. Mayo Clinic Proceedings. Vol 95 8(1613-1620).

Apicella, M., Campopiano, M. C., Mantuano, M., Mazoni, L., Coppelli, A., & Del Prato, S. (2020). COVID-19 in people with diabetes: understanding the reasons for worse outcomes. The Lancet Diabetes & Endocrinology, 8(9), 782–792.

Baker, P., White, A., & Morgan, R. (2020). Men’s health: COVID-19 pandemic highlights need for overdue policy action. The Lancet, 395(10241), 1886–1888.

Barron, E., Bakhai, C., Kar, P., Weaver, A., Bradley, D., Ismail, H., Knighton, P., Holman, N., Khunti, K., Sattar, N., Wareham, N. J., Young, B., & Valabhji, J. (2020). Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. The Lancet Diabetes & Endocrinology, 8(10), 813–822.

Basu-Ray, I., Almaddah, N. K., Adeboye, A., & Soos, M. P. (2022). Cardiac manifestations of Coronavirus (COVID-19). In StatPearls. StatPearls Publishing.

Bauer, A. Z., Gore, R., Sama, S. R., Rosiello, R., Garber, L., Sundaresan, D., McDonald, A., Arruda, P., & Kriebel, D. (2020). Hypertension, medications, and risk of severe COVID‐19: a Massachusetts community‐based observational study. The Journal of Clinical Hypertension, 23(1), 21–27.

Biswas, M., Rahaman, S., Biswas, T. K., Haque, Z., & Ibrahim, B. (2021). Association of sex, age, and comorbidities with mortality in COVID-19 patients: a systematic review and meta-analysis. Intervirology, 64(1), 36–47.

Centers for Disease Control and Prevention (2022, June 15). Science brief: evidence used to update the list of underlying medical conditions associated with higher risk for severe COVID-19.

City of Cebu (n.d.). Contact tracing strategy help boost Cebu City response. Retrieved October 15, 2022, from

CNN Philippines Staff. (2021a). DOH confirms new COVID-19 mutations in Central Visayas. CNN Philippines. Retrieved October 14, 2022, from

CNN Philippines Staff. (2021b). Despite increase in positivity rate, Cebu gov rejects recommendation of lockdown. CNN Philippines.

Dancel, R. (2020, June 29) Cebu City looms as Philippines' new Covid-19 epicentre. The Straits Times. Retrieved September 25, 2022, from

Espiritu, A. I, Sy, M. C., Anlacan, V. M., & Jamora, R. D., (2020). The Philippine COVID-19 outcomes: a retrospective study of neurological manifestations and associated symptoms (The Philippine CORONA study): a protocol study. BMJ Journal, 10(11), e040944.

Erram, M. (2021). Cebu province beefs up facilities, equipment for COVID patients. CDN. Retrieved October 2021 from

COVID-19 patients. Retrieved October 14, 2022, from

Guan, W. J., Ni, Z. Y., Hu, Y., Liang, W. H., Ou, C. Q., He, J. X., Liu, L., Shan, H., Lei, C. L., Hui, D. S., Du, B., Li, L. J., Zeng, G., Yuen, K. Y., Chen, R. C., Tang, C. L., Wang, T., Chen, P. Y., Xiang, J., . . . Zhong, N. S. (2020). Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine, 382(18), 1708–1720.

Griffith, D. M., Sharma, G., Holliday, C. S., Enyia, O. K., Valliere, M., Semlow, A. R., Stewart, E. C., & Blumenthal, R. S. (2020). Men and COVID-19: a biopsychosocial approach to understanding sex differences in mortality and recommendations for practice and policy interventions. Preventing Chronic Disease, 17.

Haghpanah, A., Masjedi, F., Salehipour, M., Hosseinpour, A., Roozbeh, J., & Dehghani, A. (2021). Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review. Prostate Cancer and Prostatic Diseases, 25(1), 27–38.

Inter-Agency Task Force for the Management of Emerging Infectious Diseases (2021). Creation of the Inter-agency task force for the management of emerging infectious diseases in the Philippines. Retrieved October 15, 2021 from

Kulkarni, S., Jenner, B. L., & Wilkinson, I. (2020). COVID-19 and hypertension. Journal of the Renin-Angiotensin-Aldosterone System, 21(2), 147032032092785.

Li, Z., Wu, M., Yao, J., Guo, J., Liao, X., Song, S., Li, J., Duan, G., Zhou, Y., Wu, X., Zhou, Z., Wang, T., Hu, M., Chen, X., Fu, Y., Lei, C., Dong, H., Xu, C., Hu, Y., . . . Yan, J. (2020). Caution on kidney dysfunctions of COVID-19 patients. SSRN Electronic Journal.

Macasero, R. (2021, March 30). Metro Cebu finally sees COVID-19 cases drop after 3-month surge. Rappler.

Magsumbol, C. N. (2021, March 25). Fewer cases, more deaths in Cebu City in March 2021. The Freeman.

Mayo Clinic Staff. (2022, September 14). Coronavirus disease 2019 (COVID-19). Mayo Clinic. .

Menon, T., Gandhi, S. A. Q., Tariq, W., Sharma, R., Sardar, S., Arshad, A. M., Adhikari, R., Ata, F., Kataria, S., & Singh, R. (2021). Impact of chronic kidney disease on severity and mortality in COVID-19 patients: a systematic review and meta-analysis. Cureus.

Pakhchanian, H., Raiker, R., Mukherjee, A., Khan, A., Singh, S., & Chatterjee, A. (2021). Outcomes of COVID-19 in CKD patients. Clinical Journal of the American Society of Nephrology, 16(5), 785–786.

Palaiodimos, L., Chamorro-Pareja, N., Karamanis, D., Li, W., Zavras, P. D., Chang, K. M., Mathias, P., & Kokkinidis, D. G. (2020). Diabetes is associated with increased risk for in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis comprising 18,506 patients. Hormones, 20(2), 305–314.

People with Certain Medical Conditions. (2022, September 2). Centers for Disease Control and Prevention. Retrieved September 25, 2022, from

Robinson, L. B., Fu, X., Bassett, I. V., Triant, V. A., Foulkes, A. S., Zhang, Y., Camargo, C. A., & Blumenthal, K. G. (2021). COVID-19 severity in hospitalized patients with asthma: A matched cohort study. The Journal of Allergy and Clinical Immunology: In Practice, 9(1), 497–500.

Sama, I. E., Ravera, A., Santema, B. T., van Goor, H., ter Maaten, J. M., Cleland, J. G. F., Rienstra, M., Friedrich, A. W., Samani, N. J., Ng, L. L., Dickstein, K., Lang, C. C., Filippatos, G., Anker, S. D., Ponikowski, P., Metra, M., van Veldhuisen, D. J., & Voors, A. A. (2020). Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin–angiotensin–aldosterone inhibitors. European Heart Journal, 41(19), 1810–1817.

Shi, Q., Zhang, X., Jiang, F., Zhang, X., Hu, N., Bimu, C., Feng, J., Yan, S., Guan, Y., Xu, D., He, G., Chen, C., Xiong, X., Liu, L., Li, H., Tao, J., Peng, Z., & Wang, W. (2020). Clinical characteristics and risk factors for mortality of COVID-19 patients with diabetes in Wuhan, China: a two-center, retrospective study. Diabetes Care, 43(7), 1382–1391.

Stiepan, D. (2022, March 22). COVID-19: Keeping seniors, immunocompromised people safe. Mayo Clinic News Network. Retrieved September 25, 2022, from

Thomas, L. (2021, August 11). COVID-19 and autoimmune Retrieved September 25, 2022, from

U.S. Embassy Manila. (2020, June 16). United States Embassy Manila, Philippines. U.S. Embassy in The Philippines. Retrieved December 4, 2021, from

WHO (2020, April). Coronavirus disease 2019 (COVID-19) Situation Report – 89.




How to Cite

Cutamora, E., Sabugal, C. B., Anonas, D. E., Maga, J. S., Leornas, P. M., & Rendon, Q. B. (2022). COVID-19 Cases In Selected Hospitals of CEBUDOC Group from March 2020 to March 2021. Journal of Scientific Investigations, 1(1), 28–40. Retrieved from